103 related articles for article (PubMed ID: 9434557)
1. [Gene therapy for diabetes].
Moritani M; Itakura M
Nihon Rinsho; 1997 Nov; 55 Suppl():739-45. PubMed ID: 9434557
[No Abstract] [Full Text] [Related]
2. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.
Moritani M; Yoshimoto K; Ii S; Kondo M; Iwahana H; Yamaoka T; Sano T; Nakano N; Kikutani H; Itakura M
J Clin Invest; 1996 Oct; 98(8):1851-9. PubMed ID: 8878437
[TBL] [Abstract][Full Text] [Related]
3. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
[TBL] [Abstract][Full Text] [Related]
4. New insights into insulin dependent diabetes mellitus from studies with transgenic mouse models.
Grewal IS; Flavell RA
Lab Invest; 1997 Jan; 76(1):3-10. PubMed ID: 9010445
[No Abstract] [Full Text] [Related]
5. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.
Giannoukakis N; Pietropaolo M; Trucco M
Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of the immunodominant B-chain of insulin reduces diabetes in a co-transfer model of diabetes in the NOD mouse and is associated with a switch from Th1 to Th2 cytokines.
Polanski M; Melican NS; Zhang J; Weiner HL
J Autoimmun; 1997 Aug; 10(4):339-46. PubMed ID: 9237797
[TBL] [Abstract][Full Text] [Related]
7. T-cell regulation in murine and human autoimmune diabetes: the role of TH1 and TH2 cells.
Heurtier AH; Boitard C
Diabetes Metab; 1997 Nov; 23(5):377-85. PubMed ID: 9416429
[TBL] [Abstract][Full Text] [Related]
8. The TCR-HA, INS-HA transgenic model of autoimmune diabetes: limitations and expectations.
Apostolou I; Von Boehmer H
J Autoimmun; 2004 Mar; 22(2):111-4. PubMed ID: 14987738
[No Abstract] [Full Text] [Related]
9. Oral insulin for diabetes prevention in NOD mice: potentiation by enhancing Th2 cytokine expression in the gut through bacterial adjuvant.
Hartmann B; Bellmann K; Ghiea I; Kleemann R; Kolb H
Diabetologia; 1997 Aug; 40(8):902-9. PubMed ID: 9267984
[TBL] [Abstract][Full Text] [Related]
10. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
11. Pathological changes in the islet milieu precede infiltration of islets and destruction of beta-cells by autoreactive lymphocytes in a transgenic model of virus-induced IDDM.
von Herrath M; Holz A
J Autoimmun; 1997 Jun; 10(3):231-8. PubMed ID: 9218748
[TBL] [Abstract][Full Text] [Related]
12. [Transgenic mouse model of type 1 diabetes mellitus].
Hosoda K; Son C; Fujikura J; Iwakura H; Tomita T; Nakao K
Nihon Rinsho; 2002 Aug; 60 Suppl 8():70-4. PubMed ID: 12355837
[No Abstract] [Full Text] [Related]
13. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
[TBL] [Abstract][Full Text] [Related]
14. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
Rothe H; Hausmann A; Casteels K; Okamura H; Kurimoto M; Burkart V; Mathieu C; Kolb H
J Immunol; 1999 Aug; 163(3):1230-6. PubMed ID: 10415018
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic strategies for Type 1 and Type 2 diabetes mellitus.
Giannoukakis N; Pietropaolo M; Trucco M
Diabetes Nutr Metab; 2002 Jun; 15(3):173-203. PubMed ID: 12173733
[TBL] [Abstract][Full Text] [Related]
16. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
Trembleau S; Penna G; Gregori S; Chapman HD; Serreze DV; Magram J; Adorini L
J Immunol; 1999 Sep; 163(5):2960-8. PubMed ID: 10453045
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor transgenic (TCR-Tg) mice from two diabetogenic CD4+ islet-antigen-specific T-cell clones.
Haskins K
J Autoimmun; 2004 Mar; 22(2):107-9. PubMed ID: 14987737
[No Abstract] [Full Text] [Related]
18. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes.
Bradley LM; Asensio VC; Schioetz LK; Harbertson J; Krahl T; Patstone G; Woolf N; Campbell IL; Sarvetnick N
J Immunol; 1999 Mar; 162(5):2511-20. PubMed ID: 10072490
[TBL] [Abstract][Full Text] [Related]
19. Utilization of NOD mice in the study of type 1 diabetes.
Karounos DG; Goes SE
Methods Mol Med; 2003; 83():81-90. PubMed ID: 12619718
[No Abstract] [Full Text] [Related]
20. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.
Wang J; Yoshida T; Nakaki F; Hiai H; Okazaki T; Honjo T
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11823-8. PubMed ID: 16087865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
